Rocket One Inc. Common Stock (NASDAQ:RKTO – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “sell” rating to a “strong sell” rating in a note issued to investors on Saturday.
RKTO has been the topic of a number of other reports. Weiss Ratings raised shares of Rocket One Inc. Common Stock from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday, June 23rd. D. Boral Capital reiterated a “buy” rating and issued a $5.00 price target on shares of Rocket One Inc. Common Stock in a report on Wednesday, March 25th. One analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $5.00.
Check Out Our Latest Research Report on RKTO
Rocket One Inc. Common Stock Trading Down 4.1%
Rocket One Inc. Common Stock (NASDAQ:RKTO – Get Free Report) last announced its quarterly earnings data on Friday, May 15th. The company reported ($0.17) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.03).
Institutional Trading of Rocket One Inc. Common Stock
Several institutional investors and hedge funds have recently made changes to their positions in RKTO. DRW Securities LLC purchased a new stake in Rocket One Inc. Common Stock in the fourth quarter worth about $257,000. Geode Capital Management LLC increased its position in Rocket One Inc. Common Stock by 18.0% during the 4th quarter. Geode Capital Management LLC now owns 181,112 shares of the company’s stock valued at $179,000 after purchasing an additional 27,577 shares during the period. Citadel Advisors LLC purchased a new position in Rocket One Inc. Common Stock during the 3rd quarter valued at about $232,000. Virtu Financial LLC bought a new stake in shares of Rocket One Inc. Common Stock in the 3rd quarter valued at about $184,000. Finally, Lido Advisors LLC raised its holdings in shares of Rocket One Inc. Common Stock by 100.0% in the 1st quarter. Lido Advisors LLC now owns 39,000 shares of the company’s stock valued at $33,000 after purchasing an additional 19,500 shares in the last quarter. 7.08% of the stock is currently owned by institutional investors.
About Rocket One Inc. Common Stock
Hoth Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on the acquisition, licensing and development of novel therapies for dermatological, central nervous system and other debilitating conditions. The company’s strategy emphasizes in-licensing late preclinical or early clinical assets with promising pharmacological profiles and leveraging formulation science to optimize delivery. Core to its approach is the design of topical and localized administration platforms intended to enhance drug penetration, sustain release and reduce systemic exposure.
Hoth’s development pipeline encompasses multiple candidate programs addressing high-unmet-need areas such as atopic dermatitis, epidermolysis bullosa and oral mucositis.
Featured Stories
- Five stocks we like better than Rocket One Inc. Common Stock
- AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector
- Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth
- TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident
- GE Aerospace Faces a Prove-It Moment in Q2 Earnings
Receive News & Ratings for Rocket One Inc. Common Stock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rocket One Inc. Common Stock and related companies with MarketBeat.com's FREE daily email newsletter.
